Research programme: hepatitis B vaccines - Johnson & Johnson Innovative Medicine/Ichor Medical Systems
Alternative Names: DNA vaccines - Johnson & Johnson Innovative Medicine/Ichor Medical Systems; Electroporation-mediated DNA vaccines - Johnson & Johnson Innovative Medicine/Ichor Medical SystemsLatest Information Update: 10 Oct 2023
At a glance
- Originator Janssen Pharmaceuticals
- Developer Ichor Medical Systems; Johnson & Johnson Innovative Medicine
- Class DNA vaccines; Hepatitis B vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Hepatitis B
Most Recent Events
- 01 Oct 2023 Janssen Pharmaceuticals is now called Johnson & Johnson Innovative Medicine (Janssen Pharmaceuticals website, October 2023)
- 28 May 2019 No recent reports of development identified for research development in Hepatitis-B in USA
- 13 Apr 2015 Early research in Hepatitis B in USA (unspecified route)